[ad_1]
A French study monitored patients with a mild form of the coronavirus. It was found that two-thirds of the 150 subjects followed continued to have some symptoms of the disease for one to two months.
It is called “Post Covid” or “Long Covid” syndrome and it would be the trace of health problems that people infected with the coronavirus carry for several weeks. Even if they got it mildly. Describing the clinical course of “non-critical” Covid-19 positives was the goal of a recent French study that followed 150 patients for two months. The research, carried out by the University Hospital of Tours, was published on Monday, October 5 in the scientific journal Clinical Microbiology and Infection (Cmi).
Problems for two thirds of the subjects studied
deepening
Covid-19 or flu: how to distinguish symptoms
The two months of descriptive clinical follow-up involved 150 patients who contracted a non-critical form of coronavirus, followed from March 17 to June 3, 2020 after recovering. On day 30 or day 60 of the study, the persistent symptoms were at least one of these: weight loss, dyspnea, shortness of breath, severe, asthenia, chest pain, palpitations, loss of sense of smell and taste, pain head, skin signs. , arthralgias, myalgias, digestive disorders and finally the presence of fever. This happened to two-thirds of the adults monitored, most often between the ages of 40 and 60. The conclusion reached by the researchers is that, therefore, whatever the initial clinical status of Covid patients, a long medical follow-up is required for all once they seem to have overcome the virus because it can happen that problems reappear even if they have. hired in a more lively way.
The numbers in detail
It was found that at thirty days 68% of the patients had at least one symptom, while 66% at sixty. Mainly it was a loss of taste and smell. 55% of the patients felt shortness of breath, while half of them on day 30 of the study (and 40% on day 60) reported asthenia, that is, loss of strength and muscle weakness. As mentioned after two months, persistent symptoms were significantly associated with positive people aged 40 to 60 years.
